Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 27, 2019 17:00 ET | Source: Molecular Templates, Inc.

New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Annual Meeting 2019

AUSTIN, Texas, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin...
February 19, 2019 16:30 ET | Source: Molecular Templates, Inc.

Molecular Templates Appoints Roger J. Waltzman, M.D., as Chief Medical Officer

AUSTIN, Texas, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary...
November 26, 2018 16:30 ET | Source: Molecular Templates, Inc.

Molecular Templates to Present at the Evercore ISI and BMO Healthcare Conferences

AUSTIN, Texas, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary...
November 13, 2018 16:30 ET | Source: Molecular Templates, Inc.

Molecular Templates, Inc. Reports Third Quarter 2018 Financial Results and Provides Corporate Update

AUSTIN, Texas, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and...
November 09, 2018 08:00 ET | Source: Molecular Templates, Inc.

Study on Molecular Templates’ PD-L1 ETB with Antigen Seeding Technology Presented at SITC Annual Meeting

Antigen Seeding Technology (AST) is a Potent and Complimentary Addition to Company’s Engineered Toxin Bodies (ETB) Technology AUSTIN, Texas, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Molecular Templates,...
September 26, 2018 08:00 ET | Source: Molecular Templates, Inc.

Molecular Templates to Present at the Ladenburg Thalmann and Cantor Healthcare Conferences

AUSTIN, Texas, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary...
September 25, 2018 16:30 ET | Source: Molecular Templates, Inc.

Molecular Templates, Inc. Announces Closing of Public Offering of Common Stock and the Full Exercise of the Underwriters’ Option to Purchase Additional Shares

AUSTIN, Texas, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of proprietary...
September 20, 2018 20:41 ET | Source: Molecular Templates, Inc.

Molecular Templates, Inc. Announces Pricing of Public Offering of Common Stock

AUSTIN, Texas, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of proprietary...
September 19, 2018 16:01 ET | Source: Molecular Templates, Inc.

Molecular Templates, Inc. Announces Proposed Public Offering of Common Stock

AUSTIN, Texas, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (the “Company” or “Molecular”), a clinical-stage oncology company focused on the discovery and development...
September 19, 2018 08:00 ET | Source: Molecular Templates, Inc.

Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy

The Agreement Will Support the Development of a Potential New Treatment Option for Multiple Myeloma AUSTIN, Texas, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM) today...